Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1988 Jan;43(1):1–8. doi: 10.1136/thx.43.1.1

Can pulmonary vasodilators improve survival in cor pulmonale due to hypoxic chronic bronchitis and emphysema?

K F Whyte 1, D C Flenley 1
PMCID: PMC461076  PMID: 3281306

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARIAS-STELLA J., SALDANA M. THE TERMINAL PORTION OF THE PULMONARY ARTERIAL TREE IN PEOPLE NATIVE TO HIGH ALTITUDES. Circulation. 1963 Nov;28:915–925. doi: 10.1161/01.cir.28.5.915. [DOI] [PubMed] [Google Scholar]
  2. Abraham A. S., Cole R. B., Bishop J. M. Reversal of pulmonary hypertension by prolonged oxygen administration to patients with chronic bronchitis. Circ Res. 1968 Jul;23(1):147–157. doi: 10.1161/01.res.23.1.147. [DOI] [PubMed] [Google Scholar]
  3. Adnot S., Defouilloy C., Brun-Buisson C., Abrouk F., Piquet J., Lemaire F. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine. Am Rev Respir Dis. 1987 Feb;135(2):288–293. doi: 10.1164/arrd.1987.135.2.288. [DOI] [PubMed] [Google Scholar]
  4. Bishop J. M., Cross K. W. Physiological variables and mortality in patients with various categories of chronic respiratory disease. Bull Eur Physiopathol Respir. 1984 Nov-Dec;20(6):495–500. [PubMed] [Google Scholar]
  5. Bishop J. M., Cross K. W. Use of other physiological variables to predict pulmonary arterial pressure in patients with chronic respiratory disease. Multicentre study. Eur Heart J. 1981 Dec;2(6):509–517. doi: 10.1093/oxfordjournals.eurheartj.a061243. [DOI] [PubMed] [Google Scholar]
  6. Bratel T., Hedenstierna G., Nyquist O., Ripe E. Long-term treatment with a new calcium antagonist, felodipine, in chronic obstructive lung disease. Eur J Respir Dis. 1986 May;68(5):351–361. [PubMed] [Google Scholar]
  7. Brent B. N., Mahler D., Berger H. J., Matthay R. A., Pytlik L., Zaret B. L. Augmentation of right ventricular performance in chronic obstructive pulmonary disease by terbutaline: a combined radionuclide and hemodynamic study. Am J Cardiol. 1982 Aug;50(2):313–319. doi: 10.1016/0002-9149(82)90182-5. [DOI] [PubMed] [Google Scholar]
  8. Brown S. E., Linden G. S., King R. R., Blair G. P., Stansbury D. W., Light R. W. Effects of verapamil on pulmonary haemodynamics during hypoxaemia, at rest, and during exercise in patients with chronic obstructive pulmonary disease. Thorax. 1983 Nov;38(11):840–844. doi: 10.1136/thx.38.11.840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Burke C. M., Harte M., Duncan J., Connolly H. M., Horgan J. H., Theodore J., Callaghan B. Captopril and domiciliary oxygen in chronic airflow obstruction. Br Med J (Clin Res Ed) 1985 Apr 27;290(6477):1251–1251. doi: 10.1136/bmj.290.6477.1251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. COTES J. E., PISA Z., THOMAS A. J. EFFECT OF BREATHING OXYGEN UPON CARDIAC OUTPUT, HEART RATE, VENTILATION, SYSTEMIC AND PULMONARY BLOOD PRESSURE IN PATIENTS WITH CHRONIC LUNG DISEASE. Clin Sci. 1963 Oct;25:305–321. [PubMed] [Google Scholar]
  11. COURNAND A., RILEY R. L. Pulmonary circulation and alveolar ventilation perfusion relationships after pneumonectomy. J Thorac Surg. 1950 Jan;19(1):80–116. [PubMed] [Google Scholar]
  12. Clozel J. P., Delorme N., Battistella P., Breda J. L., Polu J. M. Hemodynamic effects of intravenous diltiazem in hypoxic pulmonary hypertension. Chest. 1987 Feb;91(2):171–175. doi: 10.1378/chest.91.2.171. [DOI] [PubMed] [Google Scholar]
  13. Dal Nogare A. R., Rubin L. J. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986 Mar;133(3):385–389. doi: 10.1164/arrd.1986.133.3.385. [DOI] [PubMed] [Google Scholar]
  14. Filley G. F., Beckwitt H. J., Reeves J. T., Mitchell R. S. Chronic obstructive bronchopulmonary disease. II. Oxygen transport in two clinical types. Am J Med. 1968 Jan;44(1):26–38. doi: 10.1016/0002-9343(68)90234-9. [DOI] [PubMed] [Google Scholar]
  15. Fletcher E. C., Levin D. C. Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short- and long-term oxygen. Chest. 1984 Jan;85(1):6–14. doi: 10.1378/chest.85.1.6. [DOI] [PubMed] [Google Scholar]
  16. Gaucher L. R., Payen D. M., Minsart P. J., Peltier P. M., Ordronneau J. J., Grolleau J. Y. Effects of nifedipine on pulmonary arterial hypertension in patients with respiratory insufficiency without acute failure. Respiration. 1984;45(4):443–449. doi: 10.1159/000194652. [DOI] [PubMed] [Google Scholar]
  17. Gould L., Zahir M., DeMartino A., Gomprecht R. F. Haemodynamic effects of phentolamine in chronic obstructive pulmonary disease. Br Heart J. 1971 Jul;33(4):445–450. doi: 10.1136/hrt.33.4.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Harris P., Segel N., Bishop J. M. The relation between pressure and flow in the pulmonary circulation in normal subjects and in patients with chronic bronchitis and mitral stenosis. Cardiovasc Res. 1968 Jan;2(1):73–83. doi: 10.1093/cvr/2.1.73. [DOI] [PubMed] [Google Scholar]
  19. Hasleton P. S., Heath D., Brewer D. B. Hypertensive pulmonary vascular disease in states of chronic hypoxia. J Pathol Bacteriol. 1968 Apr;95(2):431–440. doi: 10.1002/path.1700950213. [DOI] [PubMed] [Google Scholar]
  20. Jezek V., Ouredník A., Stepánek J., Boudík F. The effect of aminophylline on the respiration and pulmonary circulation. Clin Sci. 1970 May;38(5):549–554. doi: 10.1042/cs0380549. [DOI] [PubMed] [Google Scholar]
  21. Jones R. M., Stockley R. A., Bishop J. M. Early effects of intravenous terbutaline on cardiopulmonary function in chronic obstructive bronchitis and pulmonary hypertension. Thorax. 1982 Oct;37(10):746–750. doi: 10.1136/thx.37.10.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Keller C. A., Shepard J. W., Jr, Chun D. S., Dolan G. F., Vasquez P., Minh V. D. Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am Rev Respir Dis. 1984 Oct;130(4):606–611. doi: 10.1164/arrd.1984.130.4.606. [DOI] [PubMed] [Google Scholar]
  23. Keller R., Ragaz A., Borer P. Predictors for early mortality in patients with long-term oxygen home therapy. Respiration. 1985;48(3):216–221. doi: 10.1159/000194832. [DOI] [PubMed] [Google Scholar]
  24. Kennedy T. P., Michael J. R., Huang C. K., Kallman C. H., Zahka K., Schlott W., Summer W. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study. Am Rev Respir Dis. 1984 Apr;129(4):544–551. [PubMed] [Google Scholar]
  25. Kennedy T., Summer W. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. Am J Cardiol. 1982 Oct;50(4):864–868. doi: 10.1016/0002-9149(82)91246-2. [DOI] [PubMed] [Google Scholar]
  26. Koziorowski A., Zielinski J., Maszczyk Z., Pawlicka L., Klimkiewicz H. Effect of salbutamol on pulmonary circulation, ventilation and gas exchange in patients with chronic obstructive airways disease. Preliminary report. Bull Physiopathol Respir (Nancy) 1972 May-Jun;8(3):611–616. [PubMed] [Google Scholar]
  27. Levine B. E., Bigelow D. B., Hamstra R. D., Beckwitt H. J., Mitchell R. S., Nett L. M., Stephen T. A., Petty T. L. The role of long-term continuous oxygen administration in patients with chronic airway obstruction with hypoxemia. Ann Intern Med. 1967 Apr;66(4):639–650. doi: 10.7326/0003-4819-66-4-639. [DOI] [PubMed] [Google Scholar]
  28. MacNee W., Connaughton J. J., Rhind G. B., Hayhurst M. D., Douglas N. J., Muir A. L., Flenley D. C. A comparison of the effects of almitrine or oxygen breathing on pulmonary arterial pressure and right ventricular ejection fraction in hypoxic chronic bronchitis and emphysema. Am Rev Respir Dis. 1986 Sep;134(3):559–565. doi: 10.1164/arrd.1986.134.3.559. [DOI] [PubMed] [Google Scholar]
  29. MacNee W., Wathen C. G., Hannan W. J., Flenley D. C., Muir A. L. Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale. Br Med J (Clin Res Ed) 1983 Oct 22;287(6400):1169–1172. doi: 10.1136/bmj.287.6400.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Matthay R. A., Berger H. J., Davies R., Loke J., Gottschalk A., Zaret B. L. Improvement in cardiac performance by oral long-acting theophylline in chronic obstructive pulmonary disease. Am Heart J. 1982 Nov;104(5 Pt 1):1022–1026. doi: 10.1016/0002-8703(82)90435-5. [DOI] [PubMed] [Google Scholar]
  31. Matthay R. A., Berger H. J., Loke J., Gottschalk A., Zaret B. L. Effects of aminophylline upon right and left ventricular performance in chronic obstructive pulmonary disease: noninvasive assessment by radionuclide angiocardiography. Am J Med. 1978 Dec;65(6):903–910. doi: 10.1016/0002-9343(78)90741-6. [DOI] [PubMed] [Google Scholar]
  32. McGregor M., Sniderman A. On pulmonary vascular resistance: the need for more precise definition. Am J Cardiol. 1985 Jan 1;55(1):217–221. doi: 10.1016/0002-9149(85)90332-7. [DOI] [PubMed] [Google Scholar]
  33. McMurtry I. F., Davidson A. B., Reeves J. T., Grover R. F. Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res. 1976 Feb;38(2):99–104. doi: 10.1161/01.res.38.2.99. [DOI] [PubMed] [Google Scholar]
  34. Melot C., Hallemans R., Naeije R., Mols P., Lejeune P. Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1984 Oct;130(4):612–616. doi: 10.1164/arrd.1984.130.4.612. [DOI] [PubMed] [Google Scholar]
  35. Milledge J. S. Angiotensin converting enzyme and hypoxia. Bull Eur Physiopathol Respir. 1984 Nov-Dec;20(6):481–485. [PubMed] [Google Scholar]
  36. Miller M. J., Chappell T. R., Cook W., De Olazabal J. R., Rubin L. J. Effects of oral hydralazine on gas exchange in patients with cor pulmonale. Am J Med. 1983 Dec;75(6):937–942. doi: 10.1016/0002-9343(83)90872-0. [DOI] [PubMed] [Google Scholar]
  37. Mitchell R. S., Stanford R. E., Silvers G. W., Dart G. The right ventricle in chronic airway obstruction: a clinicopathologic study. Am Rev Respir Dis. 1976 Jul;114(1):147–154. doi: 10.1164/arrd.1976.114.1.147. [DOI] [PubMed] [Google Scholar]
  38. Muramoto A., Caldwell J., Albert R. K., Lakshminarayan S., Butler J. Nifedipine dilates the pulmonary vasculature without producing symptomatic systemic hypotension in upright resting and exercising patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease. Am Rev Respir Dis. 1985 Nov;132(5):963–966. doi: 10.1164/arrd.1985.132.5.963. [DOI] [PubMed] [Google Scholar]
  39. Opie L. H. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review. Q J Med. 1984 Winter;53(209):1–16. [PubMed] [Google Scholar]
  40. Parker J. O., Ashekian P. B., Di Giorgi S., West R. O. Hemodynamic effects of aminophylline in chronic obstructive pulmonary disease. Circulation. 1967 Feb;35(2):365–372. doi: 10.1161/01.cir.35.2.365. [DOI] [PubMed] [Google Scholar]
  41. Parker J. O., Kelkar K., West R. O. Hemodynamic effects of aminophylline in cor pulmonale. Circulation. 1966 Jan;33(1):17–25. doi: 10.1161/01.cir.33.1.17. [DOI] [PubMed] [Google Scholar]
  42. Peacock A., Busst C., Dawkins K., Denison D. M. Response of pulmonary circulation to oral pirbuterol in chronic airflow obstruction. Br Med J (Clin Res Ed) 1983 Oct 22;287(6400):1178–1180. doi: 10.1136/bmj.287.6400.1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Romaldini H., Rodriguez-Roisin R., Wagner P. D., West J. B. Enhancement of hypoxic pulmonary vasoconstriction by almitrine in the dog. Am Rev Respir Dis. 1983 Aug;128(2):288–293. doi: 10.1164/arrd.1983.128.2.288. [DOI] [PubMed] [Google Scholar]
  44. Rubin L. J., Lazar J. D. Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction. J Clin Invest. 1981 Jan;67(1):193–200. doi: 10.1172/JCI110012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Rubin L. J., Moser K. Long-term effects of nitrendipine on hemodynamics and oxygen transport in patients with cor pulmonale. Chest. 1986 Jan;89(1):141–145. doi: 10.1378/chest.89.1.141. [DOI] [PubMed] [Google Scholar]
  46. Rubin L. J., Peter R. H. Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale. Am J Cardiol. 1981 Jan;47(1):116–122. doi: 10.1016/0002-9149(81)90299-x. [DOI] [PubMed] [Google Scholar]
  47. Rubin L. J., Peter R. H. Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med. 1980 Jan 10;302(2):69–73. doi: 10.1056/NEJM198001103020201. [DOI] [PubMed] [Google Scholar]
  48. Saadjian A., Philip-Joet F., Guintoli A., Torresani J., Arnaud A. Two-week nifedipine treatment for pulmonary hypertension complicating chronic obstructive lung disease. Eur J Respir Dis. 1985 Nov;67(5):346–350. [PubMed] [Google Scholar]
  49. Segel N., Bishop J. M. The circulation in patients with chronic bronchitis and emphysema at rest and during exercise, with special reference to the influence of changes in blood viscosity and blood volume on the pulmonary circulation. J Clin Invest. 1966 Oct;45(10):1555–1568. doi: 10.1172/JCI105462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Sime F., Peñaloza D., Ruiz L. Bradycardia, increased cardiac output, and reversal of pulmonary hypertension in altitude natives living at sea level. Br Heart J. 1971 Sep;33(5):647–657. doi: 10.1136/hrt.33.5.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Singh H., Ebejer M. J., Higgins D. A., Henderson A. H., Campbell I. A. Acute haemodynamic effects of nifedipine at rest and during maximal exercise in patients with chronic cor pulmonale. Thorax. 1985 Dec;40(12):910–914. doi: 10.1136/thx.40.12.910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Stanbrook H. S., Morris K. G., McMurtry I. F. Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists. Am Rev Respir Dis. 1984 Jul;130(1):81–85. doi: 10.1164/arrd.1984.130.1.81. [DOI] [PubMed] [Google Scholar]
  53. Stark R. D., Finnegan P., Bishop J. M. Long-term domiciliary oxygen in chronic bronchitis with pulmonary hypertension. Br Med J. 1973 Sep 1;3(5878):467–470. doi: 10.1136/bmj.3.5878.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Stein P. D., Leu J. D., Welch M. H., Guenter C. A. Pathophysiology of the pulmonary circulation in emphysema associated with alpha antitrypsin deficiency. Circulation. 1971 Feb;43(2):227–239. doi: 10.1161/01.cir.43.2.227. [DOI] [PubMed] [Google Scholar]
  55. Stockley R. A., Finnegan P., Bishop J. M. Effect of intravenous terbutaline on arterial blood gas tensions, ventilation, and pulmonary circulation in patients with chronic bronchitis and cor pulmonale. Thorax. 1977 Oct;32(5):601–605. doi: 10.1136/thx.32.5.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Studdy P. R., Lapworth R., Bird R. Angiotensin-converting enzyme and its clinical significance--a review. J Clin Pathol. 1983 Aug;36(8):938–947. doi: 10.1136/jcp.36.8.938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Sturani C., Bassein L., Schiavina M., Gunella G. Oral nifedipine in chronic cor pulmonale secondary to severe chronic obstructive pulmonary disease (COPD). Chest. 1983 Aug;84(2):135–142. doi: 10.1378/chest.84.2.135. [DOI] [PubMed] [Google Scholar]
  58. Teule G. J., Majid P. A. Haemodynamic effects of terbutaline in chronic obstructive airways disease. Thorax. 1980 Jul;35(7):536–542. doi: 10.1136/thx.35.7.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Timms R. M., Khaja F. U., Williams G. W. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med. 1985 Jan;102(1):29–36. doi: 10.7326/0003-4819-102-1-29. [DOI] [PubMed] [Google Scholar]
  60. Vik-Mo H., Walde N., Jentoft H., Halvorsen F. J. Improved haemodynamics but reduced arterial blood oxygenation, at rest and during exercise after long-term oral prazosin therapy in chronic cor pulmonale. Eur Heart J. 1985 Dec;6(12):1047–1053. doi: 10.1093/oxfordjournals.eurheartj.a061808. [DOI] [PubMed] [Google Scholar]
  61. Voelkel N. F. Mechanisms of hypoxic pulmonary vasoconstriction. Am Rev Respir Dis. 1986 Jun;133(6):1186–1195. doi: 10.1164/arrd.1986.133.6.1186. [DOI] [PubMed] [Google Scholar]
  62. WIDIMSKY J., KASALICKY J., VALACH A., DEJDAR R., VYSLOUZIL Z., LUKES M. Effect of priscol on the pulmonary circulation in cor pulmonale. Br Heart J. 1960 Sep;22:571–578. doi: 10.1136/hrt.22.4.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wallis P. J., Skehan J. D., Newland A. C., Wedzicha J. A., Mills P. G., Empey D. W. Effects of erythrapheresis on pulmonary haemodynamics and oxygen transport in patients with secondary polycythaemia and cor pulmonale. Clin Sci (Lond) 1986 Jan;70(1):91–98. doi: 10.1042/cs0700091. [DOI] [PubMed] [Google Scholar]
  64. Weitzenblum E., Jezek V. Evolution of pulmonary hypertension in chronic respiratory diseases. Bull Eur Physiopathol Respir. 1984 Jan-Feb;20(1):73–81. [PubMed] [Google Scholar]
  65. Weitzenblum E., Sautegeau A., Ehrhart M., Mammosser M., Hirth C., Roegel E. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1984 Dec;130(6):993–998. doi: 10.1164/arrd.1984.130.6.993. [DOI] [PubMed] [Google Scholar]
  66. Weitzenblum E., Sautegeau A., Ehrhart M., Mammosser M., Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1985 Apr;131(4):493–498. doi: 10.1164/arrd.1985.131.4.493. [DOI] [PubMed] [Google Scholar]
  67. Young T. E., Lundquist L. J., Chesler E., Weir E. K. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension. Am J Cardiol. 1983 Jan 1;51(1):195–200. doi: 10.1016/s0002-9149(83)80035-6. [DOI] [PubMed] [Google Scholar]
  68. Zakheim R. M., Mattioli L., Molteni A., Mullis K. B., Bartley J. Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat. Lab Invest. 1975 Jul;33(1):57–61. [PubMed] [Google Scholar]
  69. Zieliński J., Hawrylkiewicz I., Górecka D., Gluskowski J., Kościńska M. Captopril effects on pulmonary and systemic hemodynamics in chronic cor pulmonale. Chest. 1986 Oct;90(4):562–565. doi: 10.1378/chest.90.4.562. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES